ATE116546T1 - Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis. - Google Patents

Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis.

Info

Publication number
ATE116546T1
ATE116546T1 AT92103908T AT92103908T ATE116546T1 AT E116546 T1 ATE116546 T1 AT E116546T1 AT 92103908 T AT92103908 T AT 92103908T AT 92103908 T AT92103908 T AT 92103908T AT E116546 T1 ATE116546 T1 AT E116546T1
Authority
AT
Austria
Prior art keywords
products
hepatitis
acid
colomic acid
colomic
Prior art date
Application number
AT92103908T
Other languages
English (en)
Inventor
Ryoichi Osawa
Isao Suda
Masaaki Numata
Mamoru Sugimoto
Kenkichi Tomita
Nobuyuki Kibushi
Takayuki Ishii
Naokazu Sugiyama
Makiko Kasano
Chome
Tae Yasunaga
Makoto Tanaka
Tomoya Ogawa
Mariko Ishii
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6796691A external-priority patent/JPH04279526A/ja
Priority claimed from JP20842791A external-priority patent/JPH0525050A/ja
Priority claimed from JP22657891A external-priority patent/JPH0543468A/ja
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Application granted granted Critical
Publication of ATE116546T1 publication Critical patent/ATE116546T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
AT92103908T 1991-03-07 1992-03-06 Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis. ATE116546T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6796691A JPH04279526A (ja) 1991-03-07 1991-03-07 腎疾患治療薬
JP20842791A JPH0525050A (ja) 1991-07-24 1991-07-24 肝炎治療薬
JP22657891A JPH0543468A (ja) 1991-08-12 1991-08-12 免疫調整薬

Publications (1)

Publication Number Publication Date
ATE116546T1 true ATE116546T1 (de) 1995-01-15

Family

ID=27299603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92103908T ATE116546T1 (de) 1991-03-07 1992-03-06 Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis.

Country Status (8)

Country Link
US (3) US5516764A (de)
EP (1) EP0502550B1 (de)
KR (1) KR920017660A (de)
AT (1) ATE116546T1 (de)
AU (1) AU649110B2 (de)
CA (1) CA2062370A1 (de)
DE (1) DE69201066T2 (de)
DK (1) DK0502550T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904289D0 (sv) * 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2392258B1 (de) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-Informatiksystem
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP2783691A1 (de) * 2013-03-28 2014-10-01 Rheinische Friedrich-Wilhelms-Universität Bonn Polysialinsäuren und Verwendung zur Behandlung neurodegenerativer und neuroinflammatorischer Erkrankungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109688A3 (de) * 1982-11-23 1986-12-03 The Wellcome Foundation Limited Komplexe, Verfahren zu deren Herstellung und diese Komplexe enthaltende Zusammensetzungen
EP0145359B1 (de) * 1983-11-21 1991-01-16 The Wellcome Foundation Limited Komplexe, Verfahren zu ihrer Herstellung und dieselben enthaltende Formulierungen
JPH07114695B2 (ja) * 1986-06-16 1995-12-13 丸金醤油株式会社 ノイラミニダ−ゼの製造法
JPH01299294A (ja) * 1988-05-24 1989-12-04 Mect Corp ４，８−アンハイドロ−ｎ−アセチルノイラミン酸誘導体
JPH0219393A (ja) * 1988-07-08 1990-01-23 Higeta Shoyu Kk Ｎ‐アセチルガラクトサミノオリゴ糖及びその製造方法
JP2975632B2 (ja) * 1990-03-30 1999-11-10 生化学工業株式会社 グリコサミノグリカン修飾プロテイン

Also Published As

Publication number Publication date
DE69201066T2 (de) 1995-05-11
EP0502550A1 (de) 1992-09-09
DK0502550T3 (da) 1995-05-29
US5516764A (en) 1996-05-14
EP0502550B1 (de) 1995-01-04
US5668115A (en) 1997-09-16
CA2062370A1 (en) 1992-09-08
KR920017660A (ko) 1992-10-21
AU649110B2 (en) 1994-05-12
DE69201066D1 (de) 1995-02-16
US5763420A (en) 1998-06-09
AU1149492A (en) 1992-09-10

Similar Documents

Publication Publication Date Title
ATE120644T1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
ATE213733T1 (de) Zwischenprodukte zur herstellung retroviraler proteasehemmenden verbindungen
ATE25974T1 (de) Acyl-substituierte derivate von 1,2,3,4tetrahydroisochinolin-3-carboxysaeuren, ihre salze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung.
FI112471B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten hydroksietyyliaminosulfoniamidien valmistamiseksi
DE69310065T2 (de) Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose
DK0490667T3 (da) HIV-proteaseinhibitorer
FI953139A (fi) Atovakonia käsittäviä farmaseuttisia koostumuksia
ATE123944T1 (de) Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
ATE116546T1 (de) Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis.
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
NO932517L (no) 5,10-metylentetrahydrofolsyre-syklo-dekstrin-inkulusjonsforbindels er
BE1002239A5 (fr) Solution pharmaceutique.
DE69207479D1 (de) Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen
ATE135573T1 (de) Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten
ATE380789T1 (de) Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie
FR2610633B1 (fr) Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
DE69531554D1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69610045T2 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
FR2686897B1 (fr) Procede en continu de fabrication d'acides organiques.
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
FI920945A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi
IT1244728B (it) Impiego medicamentoso di derivati diidropiridinici

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee